SIO CAPITAL MANAGEMENT LLC
Q2 2024 Form 13-F
NEW YORK, NEW YORK
CIK 0001482416
· CRD 165989
· SEC-registered investment adviser
$369.5M Reported Value Total
SIO CAPITAL MANAGEMENT, LLC reports 7 total accounts under management (AUM). There are 7 discretionary accounts valued at $1,405,889,917, and 0 non-discretionary accounts.
Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
Private funds (Form ADV)
6 funds
· $864.7M gross asset value
Hedge Fund: $864.7M
Source: Form ADV filed 2026-03-18
Reported value
$369.5M
Quarter over quarter
-15.2%
Holdings
46
Top-10 concentration
68.6%
Key People
Form ADV owners & control persons
Michael Bernard Castor
MANAGING MEMBER
Judah Zvi Drillick
CHIEF EXECUTIVE OFFICER
Jin Woo Lee
CHIEF COMPLIANCE OFFICER
Filing Navigation
Coverage begins with the second quarter of 2013. Earlier quarters are not shown while their accuracy is being verified.
13F Metrics
Loading 13F Metrics
Q2 2024 13F record
Q2 2024 13F filing summary
| Period of report | June 30, 2024 |
|---|---|
| Filed | August 14, 2024 |
| Form | 13F-HR |
| Reported value | $369.5M |
| Positions | 46 |
| Change in reported value | +10.0% |
| New positions | 14 |
| Exited positions | 16 |
| Position turnover | 48.4% |
| Top-10 concentration | 68.6% |
13F filings by quarter
| Quarter | Positions | Value |
|---|---|---|
|
Q3 2026 13F
Filed Nov 16, 2026
|
51 | $528.5M |
|
Q2 2026 13F
Filed Aug 14, 2026
|
57 | $604.3M |
|
Q1 2026 13F
Filed May 14, 2026
|
73 | $697.3M |
|
Q4 2025 13F
Filed Feb 17, 2026
|
65 | $635.7M |
|
Q3 2025 13F
Filed Nov 13, 2025
|
51 | $395.2M |
|
Q2 2025 13F
Filed Aug 13, 2025
|
49 | $261.8M |
|
Q1 2025 13F
Filed May 15, 2025
|
53 | $335.8M |
|
Q4 2024 13F
Filed Feb 14, 2025
|
51 | $355.4M |
|
Q3 2024 13F
Filed Nov 14, 2024
|
38 | $252.2M |
|
Q2 2024 13F
Filed Aug 14, 2024
|
46 | $369.5M |
|
Q1 2024 13F
Filed May 15, 2024
|
48 | $335.8M |
|
Q4 2023 13F
Filed Feb 13, 2024
|
39 | $439.2M |
|
Q3 2023 13F
Filed Nov 14, 2023
|
52 | $323.1M |
|
Q2 2023 13F
Filed Aug 14, 2023
|
41 | $393.2M |
|
Q1 2023 13F
Filed May 12, 2023
|
44 | $202.3M |
|
Q4 2022 13F
Filed Feb 13, 2023
|
41 | $270.4M |
|
Q3 2022 13F
Filed Nov 14, 2022
|
43 | $314.7M |
|
Q2 2022 13F
Filed Aug 15, 2022
|
59 | $266.2M |
|
Q1 2022 13F
Filed May 16, 2022
|
61 | $302.3M |
|
Q4 2021 13F
Filed Feb 14, 2022
|
67 | $331.7M |
28 earlier quarters on file — choose one from the quarter menu above.
Top 20 holdings · Q2 2024
| # | Holding | Reported value | % of portfolio |
|---|---|---|---|
| 1 | INSM P INSMED INC | $91.3M | 24.71% |
| 2 | LH LABCORP HOLDINGS INC | $50.0M | 13.54% |
| 3 | TFX TELEFLEX INCORPORATED | $23.4M | 6.32% |
| 4 | ZBH ZIMMER BIOMET HOLDINGS INC | $16.9M | 4.56% |
| 5 | SNN SMITH & NEPHEW PLC | $14.4M | 3.89% |
| 6 | PCRX P PACIRA BIOSCIENCES INC | $13.0M | 3.53% |
| 7 | OGN ORGANON & CO | $12.6M | 3.41% |
| 8 | GSK GSK PLC | $12.0M | 3.25% |
| 9 | CRBP CORBUS PHARMACEUTICALS HLDGS | $10.2M | 2.76% |
| 10 | VXRT VAXART INC | $9.9M | 2.67% |
| 11 | TYRA TYRA BIOSCIENCES INC | $9.6M | 2.6% |
| 12 | ABT ABBOTT LABORATORIES | $9.3M | 2.52% |
| 13 | CI THE CIGNA GROUP | $8.9M | 2.4% |
| 14 | KVUE KENVUE INC | $8.8M | 2.39% |
| 15 | IRON DISC MEDICINE INC | $8.7M | 2.34% |
| 16 | ERAS ERASCA INC | $6.8M | 1.84% |
| 17 | BDSXXXXX BIODESIX INC | $6.7M | 1.8% |
| 18 | ATXS ASTRIA THERAPEUTICS INC | $4.6M | 1.26% |
| 19 | ANIP ANI PHARMACEUTICALS INC | $4.6M | 1.24% |
| 20 | BLCO BAUSCH PLUS LOMB CORP | $4.4M | 1.19% |
Values as reported on the Q2 2024 Form 13F. Every position is in the holdings table below.